Published in Brain Res on November 01, 1991
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem J (1999) 8.68
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci (2012) 4.92
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A (1994) 4.33
Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci U S A (1998) 3.74
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A (1993) 3.16
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A (1993) 2.58
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A (1993) 2.57
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A (1993) 2.41
Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys J (1998) 2.22
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med (2008) 1.90
Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci U S A (1996) 1.87
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A (2002) 1.87
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis (2006) 1.77
An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments. Biophys J (1999) 1.71
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol (2001) 1.69
Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A (2000) 1.66
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem (2011) 1.63
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50
Amyloids: friend or foe? J Alzheimers Dis (2008) 1.46
Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J (1994) 1.44
Folding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silico. Proc Natl Acad Sci U S A (2005) 1.43
α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol (2012) 1.42
Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci U S A (1992) 1.41
Solvent and mutation effects on the nucleation of amyloid beta-protein folding. Proc Natl Acad Sci U S A (2005) 1.37
NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci U S A (1995) 1.32
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol (2006) 1.29
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J (1994) 1.28
NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci (2008) 1.27
Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J (1993) 1.25
Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23
Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.17
Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis (2010) 1.17
Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci U S A (1993) 1.16
Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol (2004) 1.16
The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09
The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in β-amyloid-induced neuron death. J Biol Chem (2014) 1.06
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med (2002) 1.06
Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol (1994) 1.05
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J Neurosci (2013) 1.02
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochim Biophys Acta (2011) 1.02
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease. Alzheimers Res Ther (2014) 1.00
Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol (2004) 1.00
Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc Natl Acad Sci U S A (1996) 0.98
Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (1994) 0.98
Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage (2011) 0.98
Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? Biochem J (2012) 0.97
Genetic risk factors in Alzheimer's disease. Mol Pathol (1998) 0.97
Effect of surfaces on amyloid fibril formation. PLoS One (2011) 0.97
Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease. Aging (Albany NY) (2011) 0.95
Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci U S A (1998) 0.95
Modes of Aβ toxicity in Alzheimer's disease. Cell Mol Life Sci (2011) 0.94
On the subject of rigor in the study of amyloid β-protein assembly. Alzheimers Res Ther (2013) 0.94
Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels. Prion (2012) 0.94
Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis (2010) 0.93
Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. Int J Mol Sci (2010) 0.92
Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis. Hum Mol Genet (2013) 0.92
The hydrophobic environment of Met35 of Alzheimer's Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotox Res (2002) 0.92
Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Am J Pathol (1997) 0.91
The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem (2012) 0.91
Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. Proc Natl Acad Sci U S A (1996) 0.90
A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis (2009) 0.90
Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci U S A (1995) 0.90
Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia. ACS Chem Neurosci (2012) 0.90
Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death. Br J Pharmacol (2001) 0.89
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice. Behav Brain Res (2011) 0.88
Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A (1996) 0.87
An update on the amyloid hypothesis. Neurol Clin (2007) 0.87
Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex. Am J Pathol (2010) 0.87
Dynamics of metastable β-hairpin structures in the folding nucleus of amyloid β-protein. J Phys Chem B (2012) 0.87
Calcium in the initiation, progression and as an effector of Alzheimer's disease pathology. J Cell Mol Med (2009) 0.87
Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging. PLoS One (2013) 0.86
Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide. PLoS One (2011) 0.86
The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease. Future Sci OA (2015) 0.86
Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease. Neurobiol Aging (2013) 0.86
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. Mol Neurodegener (2009) 0.86
Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion? J Biol Inorg Chem (2008) 0.85
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein. Int J Alzheimers Dis (2011) 0.85
An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr Dis Treat (2008) 0.85
Age-related changes to tumor necrosis factor receptors affect neuron survival in the presence of beta-amyloid. J Neurosci Res (2008) 0.83
Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.83
Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line. Biochemistry (2009) 0.82
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)]. Biochem J (1998) 0.82
The last tangle of tau. J Alzheimers Dis (2008) 0.82
Design of β-amyloid aggregation inhibitors from a predicted structural motif. J Med Chem (2012) 0.82
The rat as an animal model of Alzheimer's disease. J Cell Mol Med (2009) 0.82
Resistance to the apoptotic effect of aggregated amyloid-beta peptide in several different cell types including neuronal- and hepatoma-derived cell lines. Biochem J (1998) 0.82
Amyloid beta-peptide worsens cognitive impairment following cerebral ischemia-reperfusion injury. Neural Regen Res (2013) 0.82
Protein fragments: functional and structural roles of their coevolution networks. PLoS One (2012) 0.82
Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons. Chonnam Med J (2014) 0.81
Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell Mol Neurobiol (2001) 0.81
Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats. Exp Brain Res (2005) 0.80
The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy. Curr Neuropharmacol (2006) 0.80
Responses of Cultured Astrocytes, C6 Glioma and 1321NI Astrocytoma Cells to Amyloid beta-Peptide Fragments. Nonlinearity Biol Toxicol Med (2004) 0.80
Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform. J Biomol Screen (2008) 0.80
A lifespan observation of a novel mouse model: in vivo evidence supports aβ oligomer hypothesis. PLoS One (2014) 0.79
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging (1997) 5.66
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol (1989) 4.21
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res (1996) 3.18
Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol (1999) 3.03
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology (1991) 2.77
Measurement of free electrophoretic mobility and retardation coefficient of protein-sodium dodecyl sulfate complexes by gel electrophoresis. A method to validate molecular weight estimates. J Biol Chem (1972) 2.73
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci (1985) 2.66
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Synaptic proteins. Characterization of tubulin and actin and identification of a distinct postsynaptic density polypeptide. J Cell Biol (1978) 2.44
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res (1990) 2.26
Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem (1995) 2.24
Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc (1996) 2.23
Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res (1984) 2.21
Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature (1989) 2.17
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol (1993) 2.15
Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res (1989) 2.12
Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem (1995) 1.89
Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res (1998) 1.88
Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci U S A (1992) 1.85
Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. Biochim Biophys Acta (1971) 1.84
Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett (1986) 1.83
Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis (1998) 1.81
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
Isolation of postsynaptic densities from rat brain. J Cell Biol (1974) 1.77
Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J Neurochem (1999) 1.71
Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science (1989) 1.69
Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci (2001) 1.68
Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature (1984) 1.63
Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience (2004) 1.63
Isolation and structural studies on synaptic complexes from rat brain. J Cell Biol (1972) 1.63
The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol (1996) 1.61
Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience (2005) 1.60
Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci (1998) 1.57
Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol (1991) 1.56
Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport (1991) 1.55
Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis (2001) 1.54
Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology (1999) 1.52
Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res (1983) 1.51
Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet (1995) 1.51
A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience (1995) 1.50
Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Res (1981) 1.50
Baclofen selectively inhibits excitatory synaptic transmission in the hippocampus. Brain Res (1981) 1.50
Preparation and properties of fluorescent polysaccharides. Anal Biochem (1983) 1.48
Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience (2000) 1.47
Plasticity of hippocampal circuitry in Alzheimer's disease. Science (1985) 1.46
Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci (1997) 1.45
Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res (1980) 1.44
Microlithographic determination of axonal/dendritic polarity in cultured hippocampal neurons. J Neurosci Methods (1998) 1.44
Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem (2001) 1.43
Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res (1998) 1.42
Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature (1978) 1.42
DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci (1996) 1.41
Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature (1988) 1.40
Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations. J Biol Chem (1997) 1.40
Exercise and time-dependent benefits to learning and memory. Neuroscience (2010) 1.39
Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci U S A (1988) 1.38
beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol (1994) 1.38
Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging (2006) 1.37
Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res (2001) 1.36
Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem (1997) 1.35
Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol (2001) 1.35
Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem (1991) 1.35
Surface determinants of neuronal survival and growth on self-assembled monolayers in culture. Brain Res (1993) 1.34
Glycosylation of ovalbumin nascent chains. The spatial relationship between translation and glycosylation. J Biol Chem (1980) 1.33
Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol (1996) 1.32
Species specific agglutination of eggs by bindin isolated from sea urchin sperm. Nature (1977) 1.32
Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis (2008) 1.32
Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging (1998) 1.31
Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res (1979) 1.31
Identification of glycoproteins and proteins at synapses in the central nervous system. J Biol Chem (1977) 1.29
Synapse replacement in the nervous system of adult vertebrates. Physiol Rev (1981) 1.29
Proteins of the postsynaptic density. J Cell Biol (1974) 1.27
Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42. J Biol Chem (1999) 1.27
Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science (1982) 1.26
Carbohydrate specificity of sea urchin sperm bindin: a cell surface lectin mediating sperm-egg adhesion. J Cell Biol (1982) 1.25
Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. Neurobiol Aging (2005) 1.24
Identification of a protein related to tubulin in the postsynaptic density. Proc Natl Acad Sci U S A (1977) 1.24
Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res (1993) 1.23
Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol (1980) 1.23
Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res (1997) 1.23
Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci (1995) 1.22
Olfactory classical conditioning in neonates. Pediatrics (1991) 1.21
Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging (2002) 1.21
Egg surface glycoprotein receptor for sea urchin sperm bindin. Proc Natl Acad Sci U S A (1978) 1.19
The distribution of [3H]kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res (1982) 1.19
Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol (2000) 1.19
GDEE antagonism of iontophoretic amino acid excitations in the intact hippocampus and in the hippocampal slice preparation. Brain Res (1976) 1.18
L-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis. Brain Res (1985) 1.18
Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor. Eur J Pharmacol (1989) 1.17
Resolution of insoluble proteins in rat brain subcellular fractions. Arch Biochem Biophys (1967) 1.17